Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

33.89
-0.4700-1.37%
Post-market: 33.920.0300+0.09%19:59 EDT
Volume:1.50M
Turnover:51.30M
Market Cap:3.95B
PE:-7.26
High:34.98
Open:34.79
Low:33.47
Close:34.36
52wk High:43.15
52wk Low:22.96
Shares:116.65M
Float Shares:110.00M
Volume Ratio:0.91
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:9.68
PE(LYR):-10.62

Loading ...

Jul 28, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Major Issues Report

8-K - Current report
Apr 28, 2021

Major Issues Report

8-K - Current report
Apr 28, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 08, 2021

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Feb 17, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 17, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2021

Major Issues Report

8-K - Current report
Oct 28, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2020

Major Issues Report

8-K - Current report
Aug 28, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2020

Major Issues Report

8-K - Current report
May 21, 2020

Major Issues Report

8-K - Current report
Apr 30, 2020

Major Issues Report

8-K - Current report
Apr 30, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]